Clinical Trials in Bulgaria

• A study to test Aumolertinib in European participants with genetically linked advanced Lung Cancer Ended
  2024-519618-29-00 Phase I (Other) Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Fac… Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
• A study to compare efficacy, pharmacokinetics, safety and immunogenicity of MB04 [proposed etanercept biosimilar] to Enbrel® [EU-sourced] in… Ended
  2024-510826-16-00 Phase III Rheumatoid Arthritis Mabxience Research S.L.
• Open-label basket study for safety and pharmacokinetics evaluation of INF904 in subjects with CSU or HS Ended
  2024-515615-22-00 Phase II Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Mo… InflaRx GmbH
• Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo®… Ended
  2023-507865-24-00 Phase III Advanced (unresectable/metastatic) melanoma H e x a l AG
• A comparison study between adolescents with asthma and adults with asthma on how they absorb, metabolise and eliminate CHF 6001 Ended
  2024-516483-29-00 Phase II Asthma Chiesi Farmaceutici S.p.A.
• Open-label, non-randomised, single-dose, one sequence, two-period, cross-over study to investigate the effect of inhibition of P-glycoprotei… Ended
  2024-516475-32-00 Phase I (Other) Chronic obstructive pulmonary disease Chiesi Farmaceutici S.p.A.
• Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with… Ended
  2024-514562-40-00 Phase II Hidradenitis suppurativa (HS) Avalo Therapeutics Inc.
• Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTE… Ended
  2024-517969-16-00 Phase I (Other) No therapeutic indication in the current trial with healthy … CCDRD Cooperative Clinical Drug Research and Development AG; Ioulia And Irene Ts…
• Evaluation of the bioequivalence of two products containing esomeprazole under fed conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. Nexi… Ended
  2024-512674-97-00 No therapeutic indication in the current trial with healthy … BePharBel Manufacturing; CCDRD Cooperative Clinical Drug Research and Developmen…
• A Study of the Efficacy and Safety of Brensocatib in Adults with Moderate to Severe Hidradenitis Suppurativa Ended
  2024-515959-38-00 Phase II Hidradenitis Suppurativa Insmed Inc.
• A proof-of-concept study of lunsekimig compared with placebo in adults with chronic rhinosinusitis with nasal polyps Ended
  2024-511261-11-00 Phase II Respiratory tract diseases Sanofi-Aventis Recherche & Developpement
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4… Ended
  2024-516840-24-00 Phase I (Other) Chronic Kidney disease AstraZeneca AB
• Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-2… Ended
  2024-518155-37-00 Phase I (Other) Healthy volunteers Innovative Molecules GmbH
• Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study of Efficacy and Safety of ESK-001 for Moderate to Severe Pl… Ended
  2023-507193-40-00 Phase III Moderate to Severe Plaque Psoriasis Alumis Inc.
• Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A Ended
  2023-505801-17-00 Haemophilia A Swedish Orphan Biovitrum AB (publ)
• A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania Ended
  2024-513036-26-00 Phase III Bipolar I Disorder (Bipolar Mania) Intra-Cellular Therapies Inc.
• A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania Ended
  2024-513037-20-00 Phase III Bipolar I Disorder (Bipolar Mania) Intra-Cellular Therapies Inc.
• A study to compare two different aramchol formulations in healthy volunteers. Ended
  2023-507445-28-00 Phase I (Other) Nonalcoholic fatty liver disease CCDRD Cooperative Clinical Drug Research and Development AG; Galmed Research And…
• A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended
  2024-511738-11-00 Phase III Psoriatic arthritis UCB Biopharma
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subj… Ended
  2023-508312-39-00 Phase I Chronic hepatitis B virus Infection Arbutus Biopharma Inc.
• A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral AP118… Ended
  2024-514981-37-00 Phase II Rheumatoid Arthritis Synact Pharma ApS
• A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in … Ended
  2024-511057-22-00 Phase III Major Depressive Disorder (MDD) with Moderate-to-severe Anhe… Janssen Cilag International
• A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome Ended
  2023-507680-19-00 Phase II Sjögren’s Syndrome Horizon Therapeutics Ireland Designated Activity Company
• A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a… Ended
  2024-513104-34-00 Phase II Major Depressive Disorder HMNC Holding GmbH

Showing 601–624 of 869 trials